CD8A and melanoma: Intratumoral injection of RdB/IL12/shVEGF generates massive infiltration of differentiated CD8+ and CD4+ T cells, DCs and NK cells to tissues surrounding the necrotic region of the tumor, inducing a strong antitumor effect in an immune-competent B16-F10 melanoma model [62].